Table 1 Demographics of the cohort
From: Age-associated defect in ADCC response to COVID-19 vaccine
Characteristic | N = 50a |
---|---|
Age | 79 (64, 92) |
Age Split by 80 | |
≤80 | 20 (40%) |
>80 | 30 (60%) |
Sex | |
F | 23 (46%) |
M | 27 (54%) |
dose6 | |
mRNA | 25 (50%) |
Sanofi | 25 (50%) |
From: Age-associated defect in ADCC response to COVID-19 vaccine
Characteristic | N = 50a |
---|---|
Age | 79 (64, 92) |
Age Split by 80 | |
≤80 | 20 (40%) |
>80 | 30 (60%) |
Sex | |
F | 23 (46%) |
M | 27 (54%) |
dose6 | |
mRNA | 25 (50%) |
Sanofi | 25 (50%) |